Back
argenx SE Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
30
ARGX
argenx SE
Last Price:
366.02
Seasonality Move:
20.97%
Buy
55
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.10
Seasonality Move:
-1.36%
Sell
30
argenx SE (ARGX)
is a Sell
Is argenx SE a Buy, Sell or Hold?
- The current argenx SE [ARGX] share price is $365.81. The Score for ARGX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- ARGX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Adaptimmune Therapeutics PLC (ADAP)
is a Buy
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.11. The Score for ADAP is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- ADAP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $1.11
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.
ARGX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.82 | Sell |
Relative Strength Index (14 RSI): | 43.51 | Sell |
Chaikin Money Flow: | -80142 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (364.09 - 386.25) | Sell |
Bollinger Bands (100): | (371.23 - 397.11) | Sell |
ADAP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 44.73 | Sell |
Chaikin Money Flow: | -768979 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.03 - 1.19) | Buy |
Bollinger Bands (100): | (0.89 - 1.47) | Sell |
ARGX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 372.38 | Sell |
20-day SMA: | 377.36 | Sell |
50-day SMA: | 380.32 | Sell |
200-day SMA: | 434.69 | Sell |
8-day EMA: | 372.72 | Sell |
20-day EMA: | 376.28 | Sell |
50-day EMA: | 381.35 | Sell |
200-day EMA: | 406.92 | Sell |
ADAP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.16 | Sell |
20-day SMA: | 1.14 | Sell |
50-day SMA: | 1.27 | Sell |
200-day SMA: | 0.91 | Buy |
8-day EMA: | 1.16 | Sell |
20-day EMA: | 1.16 | Sell |
50-day EMA: | 1.19 | Sell |
200-day EMA: | 1.09 | Buy |
argenx SE Earnings Growth & ARGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.69 per share, an increase next quarter of $1.50 per share, an increase this year of $1.56 per share, and an increase next year of $6.16 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and an increase next year of $0.14 per share.
argenx SE Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Adaptimmune Therapeutics PLC Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |